SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-015764
Filing Date
2016-08-11
Accepted
2016-08-11 16:06:33
Documents
80
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0616_immucellcorp.htm 10-Q 571102
2 CERTIFICATION f10q0616ex31_immucellcorp.htm EX-31 10701
3 CERTIFICATION f10q0616ex32_immucellcorp.htm EX-32 6540
10 GRAPHIC image_006.jpg GRAPHIC 73755
  Complete submission text file 0001213900-16-015764.txt   4260669

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20160630.xml EX-101.INS 758065
5 XBRL SCHEMA FILE iccc-20160630.xsd EX-101.SCH 47068
6 XBRL CALCULATION FILE iccc-20160630_cal.xml EX-101.CAL 71265
7 XBRL DEFINITION FILE iccc-20160630_def.xml EX-101.DEF 100187
8 XBRL LABEL FILE iccc-20160630_lab.xml EX-101.LAB 425126
9 XBRL PRESENTATION FILE iccc-20160630_pre.xml EX-101.PRE 279976
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 161824629
SIC: 2835 In Vitro & In Vivo Diagnostic Substances